Abstract NICE has issued the following consultation documents:
- Dasatinib and nilotinib for imatinib-resistant and/or imatinib-intolerant chronic myeloid leukaemia: technology appraisal consultation document. Closing date for comments: 7 December 2009
- Infliximab (review) and adalimumab for the treatment of Crohn's disease: technology appraisal consultation document. Closing date for comments: 10 December 2009
- Weight management following childbirth: public health guidance consultation on the evidence. Closing date for comments: 17 December 2009.
| 
